Media Contacts

Andre Salles
Office of Communication
Phone: 630-840-6733
Email: asalles@fnal.gov

Fermilab Office of Communication
Phone: 630-840-3351
Fax: 630-840-8780
Email: media@fnal.gov


Press Releases

All the news from Fermilab from 1995 through today. If you are a member of the media, write to media@fnal.gov to subscribe to our press release mailing list.

Fact Sheets and Brochures

Quick info on Fermilab's experiments and scientific, social and economic impacts.

Office of Communication

Need to arrange an interview with an expert, get background materials or take an emergency physics lesson on a deadline? Our Office of Communication staff is here to help.

Photo Archive

Hi-res images and graphics from Fermilab's online database.

Video Archive

Animations and videos available for streaming and download.

Breaking News Resources

Other Fermilab Resources

Spotlight

Spotlight

photo
New high-speed transatlantic network to benefit science collaborations across the U.S.
ESnet will build a high-speed extension for faster data exchange between United States and Europe.
photo
Fermilab's 500-mile neutrino experiment up and running
With construction completed, the NOvA experiment has begun its probe into the mysteries of ghostly particles that may hold the key to understanding the universe.
photo
Videos: NOvA in action
Go behind the scenes of the creation of the NOvA far detector and see what the NOvA detector sees in two new videos on the NOvA experiment.
photo
Top quark still raising questions
Scientists are still interested in the heaviest fundamental particle, nearly 20 years after its discovery.
photo
Fermilab Campus Master Plan
The implementation of the Fermilab Campus Master Plan will position Fermilab as one of the top research destinations of choice for present and future generations of particle physicists.
photo
Accelerating the fight against cancer
As charged-particle therapies grow in popularity, physicists are working with other experts to make them smaller, cheaper and more effective — and more available to cancer patients in the United States.